[Report] Serialization: How to move from investment to insight

We share five areas where you can use serialization to drive results and build ROI

Pharma IQ

We respect your privacy, by clicking "Download Your Copy" you will receive our e-newsletter, including information on Podcasts, Webinars, event discounts, online learning opportunities and agree to our User Agreement. You have the right to object . In addition, you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest subject to their privacy policy. For further information on how we process and monitor your personal data click here. You can unsubscribe at any time.

Following the enforcement of the EU Falsified Medicines Directive and the US Drug Supply Chain Security Act, many companies have had to invest substantially to meet the serialization requirements.

Compliance to these regulations has come at a heavy price, both financially and operationally.

This has been especially true for companies operating a high-volume, low-margin business model or those facing pressure to reduce costs.

Post serialization deadline, the overriding focus has been on ensuring compliance for all relevant product lines.

However, now that many companies are fully underway with their compliance initiatives, attention is shifting to how the serialization infrastructure could be utilized to generate value.

Companies are starting to test out initiatives to optimize processes, improve decision making and increase responsiveness using their new systems and data.

In this report, we’ll discuss 5 areas where you can use serialized data to generate commercial value

We'll cover how you can:

  • Gain oversight on supply chain operations
  • Ensure accurate returns management
  • Act quickly on pressing issues
  • Track and action trends
  • Facilitate supply chain collaboration

Download your copy of the report now!

To continue reading this story get free access